Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Cash Flow-to-Debt Ratio
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥18.31 Million could theoretically repay 0% of its total liabilities (CN¥2.27 Billion) in one year. See Jiangxi Fushine Pharmaceutical Co Ltd (300497) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangxi Fushine Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Jiangxi Fushine Pharmaceutical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see 300497 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Year-by-year debt coverage analysis for Jiangxi Fushine Pharmaceutical Co Ltd. Check Jiangxi Fushine Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | CN¥62.67 Million | CN¥2.20 Billion | ▼ -64.2% |
| 2024 | 0.08x | CN¥187.64 Million | CN¥2.36 Billion | ▲ +388.3% |
| 2023 | -0.03x | CN¥-64.76 Million | CN¥2.35 Billion | ▲ +45.9% |
| 2022 | -0.05x | CN¥-120.85 Million | CN¥2.37 Billion | ▼ -224.6% |
| 2021 | 0.04x | CN¥72.32 Million | CN¥1.77 Billion | ▼ -89.3% |
| 2020 | 0.38x | CN¥382.35 Million | CN¥997.93 Million | ▲ +21.1% |
| 2019 | 0.32x | CN¥337.91 Million | CN¥1.07 Billion | ▲ +88.8% |
| 2018 | 0.17x | CN¥175.91 Million | CN¥1.05 Billion | ▼ -34.6% |
| 2017 | 0.26x | CN¥210.72 Million | CN¥822.70 Million | ▼ -16.6% |
| 2016 | 0.31x | CN¥188.53 Million | CN¥614.20 Million | ▲ +71.5% |
| 2015 | 0.18x | CN¥74.01 Million | CN¥413.44 Million | ▲ +99.1% |
| 2014 | 0.09x | CN¥31.39 Million | CN¥349.09 Million | ▼ -51.0% |
| 2013 | 0.18x | CN¥57.22 Million | CN¥311.55 Million | ▼ -15.2% |
| 2012 | 0.22x | CN¥63.20 Million | CN¥291.70 Million | ▲ +48.7% |
| 2011 | 0.15x | CN¥33.80 Million | CN¥232.04 Million | — |